STM increases fatty acid β-oxidation in adipose tissue by upregulatingKat-1, which encodes 3-ketoacyl-coA-thiolase, a critical enzyme of fatty acid β-oxidation, preventing HFD-induced hyperlipidemia and insulin resistance[18]. The gene discussed is HADHB; the disease is hyperlipidemia.